Who owns VISTAGEN THERAPEUTICS ORD?
- Ticker: VTGN
- CUSIP Number: 92840h400
Tip: Access positions for across all investors
Analyze quarterly positions in Vistagen Therapeutics Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Vistagen Therapeutics Ord stock
Who bought or sold VISTAGEN THERAPEUTICS ORD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| OrbiMed Advisors | 3.1M | $1.7M | -1% | Mar 2026 |
|
| TCG Crossover Management | 2.7M | $1.5M | 0% | Mar 2026 |
|
| Vanguard Group | 1.8M | $1.2M | 8% | Dec 2025 |
|
| Vanguard Capital Management | 1.6M | $900k | 100% | Mar 2026 |
|
| Susquehanna International | 825k | $546k | 149% | Dec 2025 |
|
| ADAR1 Capital Management | 751k | $429k | 1% | Mar 2026 |
|
| Millennium Management | 644k | $368k | 227% | Mar 2026 |
|
| Stempoint Capital | 617k | $58k | 0% | Mar 2026 |
|
| Acadian Asset Management | 590k | $336k | 100% | Mar 2026 |
|
| Ikarian Capital | 519k | $297k | 0% | Mar 2026 |
|
| Two Sigma Investments | 470k | $268k | 140% | Mar 2026 |
|
| Geode Capital Management | 453k | $259k | 28% | Mar 2026 |
|
| BlackRock | 449k | $256k | 6% | Mar 2026 |
|
| Luminus Management | 396k | $226k | 13% | Mar 2026 |
|
| Jane Street | 296k | $169k | -51% | Mar 2026 |
|
| AdvisorShares Investments | 277k | $158k | 11% | Mar 2026 |
|
| Citadel Advisors | 275k | $157k | -68% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 218k | $125k | 100% | Mar 2026 |
|
| Diadema Partners | 207k | $137k | -54% | Dec 2025 |
|
| Renaissance Technologies | 161k | $106k | -62% | Dec 2025 |
|
| Shay Capital | 145k | $83k | 100% | Mar 2026 |
|
| Boothbay Fund Management | 135k | $77k | 0% | Mar 2026 |
|
| State Street Corporation | 121k | $80k | 25% | Dec 2025 |
|
| Tudor Investment Corporation | 106k | $61k | 39% | Mar 2026 |
|
| UBS Group | 79k | $45k | 51% | Mar 2026 |
|
| Caption Management | 78k | $52k | 100% | Dec 2025 |
|
| Northern Trust | 73k | $48k | 51% | Dec 2025 |
|
| Qube Research & Technologies | 60k | $40k | 100% | Dec 2025 |
|
| Prudential Financial | 53k | $30k | 100% | Mar 2026 |
|
| GSA Capital Partners | 50k | $28k | 100% | Mar 2026 |
|
| American Century Companies | 49k | $32k | 19% | Dec 2025 |
|
| Virtu Financial | 38k | $25k | 100% | Dec 2025 |
|
| Engineers Gate Manager | 31k | $20k | 100% | Dec 2025 |
|
| Persistent Asset Partners | 27k | $15k | 0% | Mar 2026 |
|
| Schonfeld Strategic Advisors | 27k | $15k | 22% | Mar 2026 |
|
| Kestra Advisory Services | 26k | $15k | 0% | Mar 2026 |
|
| Hrt Financial | 25k | $14k | -32% | Mar 2026 |
|
| Charles Schwab Investment Management | 23k | $15k | 0% | Dec 2025 |
|
| HighTower Advisors | 21k | $12k | 0% | Mar 2026 |
|
| Lighthouse Investment Partners | 21k | $14k | 100% | Dec 2025 |
|
| Marshall Wace | 20k | $13k | 100% | Dec 2025 |
|
| Group One Trading | 20k | $11k | -81% | Mar 2026 |
|
| Truvestments Capital | 17k | $9.7k | 0% | Mar 2026 |
|
| Two Sigma Securities | 17k | $9.4k | 100% | Mar 2026 |
|
| Intl Fcstone | 15k | $8.7k | 14% | Mar 2026 |
|
| Vanguard Global Advisers | 11k | $6.2k | 100% | Mar 2026 |
|
| Tower Research Capital | 8.6k | $5.7k | 100% | Dec 2025 |
|
| Performa | 7.5k | $4.3k | 650% | Mar 2026 |
|
| Advisor Group Holdings | 5.3k | $3.5k | 29% | Dec 2025 |
|
| Royal Bank of Canada | 2.1k | $999.902700 | 100% | Mar 2026 |
|
| Annis Gardner Whiting Capital Advisors | 600.00 | $343.020000 | 100% | Mar 2026 |
|
| CWM | 582.00 | $0 | 0% | Dec 2025 |
|
| MAI Wealth Advisors | 526.00 | $300.977200 | 0% | Mar 2026 |
|
| SBI Securities | 288.00 | $164.995200 | 0% | Mar 2026 |
|
| Jones Financial Companies, L.L | 114.00 | $75.000600 | 0% | Dec 2025 |
|
| Fairman Group | 29.00 | $16.999800 | 0% | Mar 2026 |
|
| Northwestern Mutual Wealth Management Company | 16.00 | $9.000000 | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 13.00 | $7.000500 | 0% | Mar 2026 |
|
| Citigroup | 1.00 | $1.000000 | 100% | Mar 2026 |
|
| Morgan Stanley | 1.00 | $1.000000 | -100% | Mar 2026 |
|
Who sold out of Vistagen Therapeutics Ord?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Henderson Group | Sep 2025 | 4.2M | $15M |
| Jpmorgan Chase & Co | Sep 2025 | 272k | $965k |
| Dimensional Fund Advisors | Dec 2025 | 152k | $101k |
| Two Sigma Advisers | Dec 2025 | 138k | $91k |
| OMERS Administration Corporation | Dec 2025 | 103k | $68k |
| XTX Topco | Sep 2025 | 70k | $248k |
| Seven Fleet Capital Management | Dec 2025 | 63k | $42k |
| Occudo Quantitative Strategies | Dec 2025 | 59k | $39k |
| None | Dec 2025 | 20k | $13k |
| DRW Holdings | Dec 2025 | 10k | $6.6k |
| Barclays | Sep 2025 | 1.00 | $4.000000 |